Dow Up0.64% Nasdaq Up0.68%

TG Therapeutics, Inc. (TGTX)

-NasdaqCM
11.56 0.04(0.34%)
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 152   19   -  
Cost of Revenue -   -   -  
Gross Profit 152   19   -  
Operating Expenses
Research Development13,663  21,028  327  
Selling General and Administrative6,658  4,781  555  
Non Recurring2,798  1,105   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (22,966) (26,895) (882)
Income from Continuing Operations
Total Other Income/Expenses Net3,441  1,948   -  
Earnings Before Interest And Taxes(19,525)(24,947)(882)
Interest Expense953  906  7  
Income Before Tax(20,478)(25,853)(889)
Income Tax Expense -  330   -  
Minority Interest -  8,110  36  
Net Income From Continuing Ops(20,478)(18,073)(853)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (20,478) (18,073) (853)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (20,478) (18,073) (853)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.